EBITDA: Income before interest, taxes, depreciation and amortization.
Kiromic BioPharma, Inc. (KRBPQ) had EBITDA of $-21.54M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-33.73M |
|
-- |
|
-- |
|
$23.77M |
|
$-23.77M |
|
$-3.12M |
|
$-26.90M |
|
$-26.90M |
|
$-26.90M |
|
$-26.90M |
|
$-26.90M |
|
$-26.90M |
|
$-23.77M |
|
|
EBITDA |
$-21.54M |
1.46M |
|
1.46M |
|
$-3.17 |
|
$-3.17 |
|
| Balance Sheet Financials | |
$3.30M |
|
$4.31M |
|
$5.24M |
|
$8.54M |
|
$20.90M |
|
-- |
|
$0.23M |
|
$21.13M |
|
$-12.59M |
|
$-12.59M |
|
$-12.59M |
|
1.53M |
|
| Cash Flow Statement Financials | |
$-19.46M |
|
$-0.37M |
|
$18.41M |
|
$3.20M |
|
$1.79M |
|
$-1.41M |
|
$0.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.16 |
|
-- |
|
-- |
|
-- |
|
-1.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
213.70% |
|
213.70% |
|
-314.78% |
|
213.70% |
|
$-8.21 |
|
$-13.57 |
|
$-13.32 |
|